| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.06B | 26.83B | 25.01B | 23.35B | 20.14B | 19.15B |
| Gross Profit | 6.28B | 7.51B | 6.23B | 5.32B | 4.90B | 4.66B |
| EBITDA | 1.99B | 2.66B | 2.07B | 1.69B | 1.38B | 1.12B |
| Net Income | 1.16B | 1.43B | 1.18B | 459.00M | 425.00M | 434.00M |
Balance Sheet | ||||||
| Total Assets | 31.14B | 34.06B | 27.68B | 27.25B | 25.70B | 25.43B |
| Cash, Cash Equivalents and Short-Term Investments | 3.77B | 2.35B | 2.02B | 1.63B | 1.39B | 3.44B |
| Total Debt | 12.54B | 10.55B | 8.09B | 8.10B | 8.50B | 8.92B |
| Total Liabilities | 21.65B | 21.58B | 17.50B | 18.28B | 17.69B | 17.55B |
| Stockholders Equity | 9.48B | 12.48B | 10.17B | 8.96B | 8.01B | 7.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.23B | 931.00M | 711.00M | -1.66B | -895.00M |
| Operating Cash Flow | 0.00 | 3.41B | 1.50B | 1.61B | -534.00M | 284.00M |
| Investing Cash Flow | 0.00 | -3.86B | -817.00M | -804.00M | -933.00M | -1.19B |
| Financing Cash Flow | 0.00 | 780.00M | -337.00M | -583.00M | -597.00M | -1.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥18.40B | 25.01 | ― | 2.78% | 5.18% | 37.11% | |
70 Outperform | ¥256.63B | 11.89 | 16.64% | 1.36% | -0.12% | -17.83% | |
64 Neutral | ¥16.22B | 7.06 | ― | 0.27% | 5.30% | 126.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥9.16B | 6.33 | ― | 2.71% | 7.29% | 20.12% | |
59 Neutral | ¥429.24B | 11.17 | 13.69% | 0.60% | 12.09% | -1.60% | |
52 Neutral | ¥3.28B | 17.83 | ― | 0.67% | 6.22% | 385.27% |